A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer

NCT00001426 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

NIH

Sponsor class

Conditions

Ovarian Neoplasm

Interventions

DRUG: Cyclophosphamide
DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: G-CSF

Sponsor

National Cancer Institute (NCI)